diabetes mellitus type 2: how to avoid errors and to increase the effectiveness of rreatment
Clicks: 246
ID: 254436
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
246 views
29 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #33 of 79 articles by views in Macromolecular rapid communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article considers the urgency of the problem of diabetes mellitus incidence (DM) in the world today. It is emphasized that at the present stage of development of diabetology main goal of DM treatment is to achieve blood glucose levels, as close as possible to the physiological ones, without increasing the risk of hypoglycemia and without harm to the quality of life of patients. Attention is paid to the treatment with emphasis on the fact that priority should be given to drugs with minimal risk of hypoglycemia, and while choosing the combination therapy is is particularly important to consider the use of drugs with mechanisms of action that complement each other. Separately, the reasons of failures in the treatment and in the disease compensations are considered.
| Reference Key |
pankiv2013mnarodnijdiabetes
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;V.I. Pankiv |
| Journal | Macromolecular rapid communications |
| Year | 2013 |
| DOI |
10.22141/2224-0721.4.52.2013.84441
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.